Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms

S. A. Gujar; D. Clements; R. Dielschneider; E. Helson; P. Marcato; P. W.K. Lee

doi:10.1038/bjc.2013.695

Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms

S. A. Gujar, D. Clements, R. Dielschneider, E. Helson, P. Marcato, P. W.K. Lee

科研成果: 期刊稿件 › 文章 › 同行评审

源语言	英语
页（从-至）	83-93
页数	11
期刊	British Journal of Cancer
卷	110
期	1
DOI	https://doi.org/10.1038/bjc.2013.695
出版状态	已出版 - 2014

!!!ASJC Scopus Subject Areas

肿瘤学
癌症研究

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1038/bjc.2013.695

其它文件与链接

引用此

Gujar, S. A., Clements, D., Dielschneider, R., Helson, E., Marcato, P., & Lee, P. W. K. (2014). Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms. British Journal of Cancer, 110(1), 83-93. https://doi.org/10.1038/bjc.2013.695

@article{3a77ddeb963f45f984b63ce8027831eb,

title = "Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms",

keywords = "MDSCs, anti-tumour immunity, gemcitabine, oncotherapy, reovirus",

author = "Gujar, {S. A.} and D. Clements and R. Dielschneider and E. Helson and P. Marcato and Lee, {P. W.K.}",

note = "Funding Information: This work was supported by an operating grant from the Canadian Institute of Health Research (CIHR) to PWKL. SG is currently funded by a CIHR Postdoctoral Fellowship, and was funded through Cancer Research Training Program (CRTP) in the past. EH received a Norah Stephen Summer Studentship from Beatrice Hunter Cancer Research Institute.",

year = "2014",

doi = "10.1038/bjc.2013.695",

language = "English",

volume = "110",

pages = "83--93",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms

AU - Gujar, S. A.

AU - Clements, D.

AU - Dielschneider, R.

AU - Helson, E.

AU - Marcato, P.

AU - Lee, P. W.K.

N1 - Funding Information: This work was supported by an operating grant from the Canadian Institute of Health Research (CIHR) to PWKL. SG is currently funded by a CIHR Postdoctoral Fellowship, and was funded through Cancer Research Training Program (CRTP) in the past. EH received a Norah Stephen Summer Studentship from Beatrice Hunter Cancer Research Institute.

PY - 2014

Y1 - 2014

KW - MDSCs

KW - anti-tumour immunity

KW - gemcitabine

KW - oncotherapy

KW - reovirus

UR - http://www.scopus.com/inward/record.url?scp=84891859522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891859522&partnerID=8YFLogxK

U2 - 10.1038/bjc.2013.695

DO - 10.1038/bjc.2013.695

M3 - Article

C2 - 24281006

AN - SCOPUS:84891859522

SN - 0007-0920

VL - 110

SP - 83

EP - 93

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 1

ER -

Gemcitabine enhances the efficacy of reovirus-based oncotherapy through anti-tumour immunological mechanisms

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此